Cardiometabolic Effects of Combined Aerobic Exercise and Non-Exercise Physical Activity
Cardiometabolic Effects of Increasing Non-Exercise Physical Activity Combined With Aerobic Exercise in Overweight Young Women
1 other identifier
interventional
28
1 country
1
Brief Summary
The goal of this clinical trial is to investigate whether increasing non-exercise physical activity combined with aerobic exercise in overweight young women is superior to performing aerobic exercise alone in terms of some cardiometabolic variables. The main question it aims to answer is: • Do both increasing non-exercise physical activity and doing aerobic exercise add more beneficial cardiometabolic effects to performing aerobic exercise alone in overweight young women? To answer this question, overweight young women will be randomly assigned to two different groups of this research. Volunteers in one of the groups will do moderate-intensity aerobic training and the other group will increase their non-exercise physical activities in addition to moderate-intensity aerobic training. Then researchers will compare two groups to see the differences in cardiometabolic variables.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Mar 2024
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
February 14, 2024
CompletedFirst Posted
Study publicly available on registry
February 21, 2024
CompletedStudy Start
First participant enrolled
March 11, 2024
CompletedPrimary Completion
Last participant's last visit for primary outcome
June 18, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
September 1, 2025
CompletedJanuary 6, 2026
December 1, 2025
1.3 years
February 14, 2024
December 31, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (8)
Low Density Lipoprotein (LDL) Cholesterol
Fasting blood samples will be taken by applying a vacutainer needle to the appropriate vein following a 12-hour fast and will be analyzed immediately in the biochemistry laboratory.
The week before the beginning of the interventions, at 4th week of the intervention , and the week after the interventions
High Density Lipoprotein (HDL) Cholesterol
Fasting blood samples will be taken by applying a vacutainer needle to the appropriate vein following a 12-hour fast and will be analyzed immediately in the biochemistry laboratory.
The week before the beginning of the interventions, at 4th week of the intervention , and the week after the interventions
Total Cholesterol
Fasting blood samples will be taken by applying a vacutainer needle to the appropriate vein following a 12-hour fast and will be analyzed immediately in the biochemistry laboratory.
The week before the beginning of the interventions, at 4th week of the intervention , and the week after the interventions
Glycated Hemoglobin (HbA1C)
Fasting blood samples will be taken by applying a vacutainer needle to the appropriate vein following a 12-hour fast and will be analyzed immediately in the biochemistry laboratory.
The week before the beginning of the interventions, at 4th week of the intervention , and the week after the interventions
Serum Triglycerides
Fasting blood samples will be taken by applying a vacutainer needle to the appropriate vein following a 12-hour fast and will be analyzed immediately in the biochemistry laboratory.
The week before the beginning of the interventions, at 4th week of the intervention , and the week after the interventions
Maximal Oxygen Consumption
Maximal oxygen consumption will be estimated by the Rockport 1 Mile Walk Test
The week before the beginning of the interventions, and the week after the interventions
Systolic Blood Pressure
Measurements will be made on the arm with a digital blood pressure monitor after resting for at least 10 minutes in a supine position to ensure hemodynamic stability. By wrapping the cuff around the arm, brachial systolic blood pressure will be automatically measured.
The week before the beginning of the interventions, at 4th week of the intervention , and the week after the interventions
Diastolic Blood Pressure
Measurements will be made on the arm with a digital blood pressure monitor after resting for at least 10 minutes in a supine position to ensure hemodynamic stability. By wrapping the cuff around the arm, brachial diastolic blood pressure will be automatically measured.
The week before the beginning of the interventions, at 4th week of the intervention , and the week after the interventions
Secondary Outcomes (4)
Body Fat Percentage
The week before the beginning of the interventions, at 4th week of the intervention , and the week after the interventions
Fat-free Mass
The week before the beginning of the interventions, at 4th week of the intervention , and the week after the interventions
Waist Circumference
The week before the beginning of the interventions, at 4th week of the intervention , and the week after the interventions
Hip Circumference
The week before the beginning of the interventions, at 4th week of the intervention , and the week after the interventions
Study Arms (2)
Aerobic Exercise (AeroEx) Group
EXPERIMENTALParticipants in this group will do moderate-intensity aerobic training for 4 days a week for 8 weeks.
Aerobic Exercise+non-Exercise (nE) Physical Activity (AeroEx+nE PA) Group
EXPERIMENTALParticipants in this group will increase their non-exercise physical activities and do moderate-intensity aerobic training for four days a week for 8 weeks.
Interventions
Aerobic exercise will be performed on the treadmill at 40-60% of the participants' heart rate reserves. Each aerobic exercise session will last for 40 minutes. All participants will be monitored with a heart rate monitor throughout the exercise sessions. During the first three-week, participants will exercise on the treadmill at intensities between 40-50%, and between fourth and eighth weeks, 50-60% of their heart rate reserves. Participants will wear an accelerometer on their non-dominant wrist during the intervention to monitor the physical activity and sedentary behavior data. At the same time, these participants will be asked not to change their routine diet during the intervention period.
Participants who will carry out this intervention will increase their non-exercise physical activities. Before intervention period, participants will receive face-to-face training to increase their non-exercise physical activities. This training will generally consist of recommendations based on the study which effectively reduced sedentary behavior (SB) with non-exercise physical activities (Sarah Kozey-Keadle et al. 2012). A one-on-one interview will be held with each participant every week to learn about strategies by which the volunteers successfully increased their non-exercise physical activities in the previous week, and the difficulties or barriers they encountered. New strategies to overcome these difficulties and barriers will be discussed and suggestions will be made. Participants will wear an accelerometer on their non-dominant wrist to monitor the physical activity and SB data, and will be asked not to change their routine diet during the intervention period.
Eligibility Criteria
You may qualify if:
- To have a body mass index between 25 kg.(m2)-1 and 29.9 kg.(m2)-1
- Self reported sitting time greater than 7 hours per day
- Not exercising regularly in the last 3 months
You may not qualify if:
- Hypertension
- Coronary heart disease
- Heart failure
- Diabetes mellitus (A1C being 6.5% and above)
- Prediabetes (A1C between 5.7% and 6.4%)
- Metabolic syndrome
- Hypothyroidism
- Non-alcoholic fatty liver disease
- Chronic inflammatory disease
- Chronic renal failure
- Cushing's syndrome
- Musculoskeletal disorder that will affect the ability to do physical activity
- HIV infection
- Being on antihypertensive medication
- Being on lipid-lowering medication
- +4 more criteria
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Kastamonu University, Çatalzeytin Vocational School
Çatalzeytin, Kastamonu, 37, Turkey (Türkiye)
Related Publications (2)
Kozey-Keadle S, Libertine A, Staudenmayer J, Freedson P. The Feasibility of Reducing and Measuring Sedentary Time among Overweight, Non-Exercising Office Workers. J Obes. 2012;2012:282303. doi: 10.1155/2012/282303. Epub 2011 Nov 16.
PMID: 22175004BACKGROUNDKozey Keadle S, Lyden K, Staudenmayer J, Hickey A, Viskochil R, Braun B, Freedson PS. The independent and combined effects of exercise training and reducing sedentary behavior on cardiometabolic risk factors. Appl Physiol Nutr Metab. 2014 Jul;39(7):770-80. doi: 10.1139/apnm-2013-0379. Epub 2014 Jan 7.
PMID: 24971677BACKGROUND
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- OUTCOMES ASSESSOR
- Purpose
- PREVENTION
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Principal Investigator
Study Record Dates
First Submitted
February 14, 2024
First Posted
February 21, 2024
Study Start
March 11, 2024
Primary Completion
June 18, 2025
Study Completion
September 1, 2025
Last Updated
January 6, 2026
Record last verified: 2025-12